drug
dinutuximab
Marketedupdated 3mo agoby $UTHR UNITED THERAPEUTICS Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying dinutuximab
- phase2Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
- phase2NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- phase1Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
- phase2A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- phase1Rapid Administration Pilot for Infusing Dinutuximab
- phase2NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
- phase2Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
- phase1Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that